Alpha-1 Antitrypsin

DRUG3 trials

Sponsors

Rabin Medical Center, Kamada, Ltd., University of Alberta

Conditions

Bronchiolitis Obliterable SyndromeLung TransplantationNew Onset Type-1 DiabetesType 1 Diabetes Mellitus

Phase 1

Aralast NP in Islet Transplant

CompletedNCT02520076

University of AlbertaType 1 Diabetes Mellitus

Start: 2015-08-31End: 2019-09-30Updated: 2022-05-24

Phase 2

Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients

Rabin Medical CenterBronchiolitis Obliterable Syndrome, Lung Transplantation

Start: 2011-09-30End: 2013-09-30Target: 40Updated: 2011-07-14

Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes

CompletedNCT02005848

Kamada, Ltd.New Onset Type-1 Diabetes

Start: 2014-04-30End: 2017-02-28Updated: 2018-10-11